L-tyrosine is a promising cancer vaccine adjuvant
نویسندگان
چکیده
منابع مشابه
L-tyrosine is a promising cancer vaccine adjuvant
The choice of adjuvants is critical for any vaccine whether prophylactic or therapeutic. Our group previously showed that incomplete Freund’s adjuvant, commonly used in different cancer vaccine trials, had many undesirable effects on T cell trafficking and function which directly translates into poor anti-tumor efficacy in preclinical murine model. Switching from oil-based (IFA) to water based ...
متن کاملPromising lung cancer vaccine.
Background: The satisfaction and the quality of life perceived by professionals have implications for the performance of health organizations. We have assessed the variations in professional quality of life (PQL) and their explanatory factors during a services management decentralization process. Methods: It was designed as a longitudinal analytical observational study in a Health Area in Madri...
متن کاملAlginate Nanoparticles as a Promising Adjuvant and Vaccine Delivery System
During last decades, diphtheria has remained as a serious disease that still outbreaks and can occur worldwide. Recently, new vaccine delivery systems have been developed by using the biodegradable and biocompatible polymers such as alginate. Alginate nanoparticles as a carrier with adjuvant and prolong release properties that enhance the immunogenicity of vaccines. In this study diphtheria tox...
متن کاملGanoderma spp.: A Promising Adjuvant Treatment for Breast Cancer
For the past several decades, cancer patients in the U.S. have chosen the use of natural products as an alternative or complimentary medicine approach to treat or improve their quality of life via reduction or prevention of the side effects during or after cancer treatment. The genus Ganoderma includes about 80 species of mushrooms, of which several have been used for centuries in traditional A...
متن کاملFlagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer
Cervical cancer is a high-incidence female cancer most commonly caused by human papilloma virus (HPV) infection of the genital mucosa. Immunotherapy targeting HPV-derived tumor antigens (TAs) has been widely studied in animal models and in patients. Because the female genital tract is a portal for the entry of HPV and a highly compartmentalized system, the development of topical vaginal immunot...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal for ImmunoTherapy of Cancer
سال: 2015
ISSN: 2051-1426
DOI: 10.1186/2051-1426-3-s2-p440